Cantor Sees Possible Acquisitions For Valeant Pharmaceuticals In 2015 By: Benzinga via Benzinga December 30, 2014 at 15:00 PM EST Cantor Fitzgerald analyst Daniel Brims commented Tuesday that Valeant Pharmaceuticals Intl Inc. (NYSE: VRX) may make dental ... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.